Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Unlocking the power of nanomedicine: the future of nutraceuticals in oncology treatment

M. Singla, . Smriti, S. Gupta, P. Behal, SK. Singh, S. Preetam, S. Rustagi, J. Bora, P. Mittal, S. Malik, P. Slama

. 2023 ; 10 (-) : 1258516. [pub] 20231117

Status not-indexed Language English Country Switzerland

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc23022490

Cancer, an intricate and multifaceted disease, is characterized by the uncontrolled proliferation of cells that can lead to serious health complications and ultimately death. Conventional therapeutic strategies mainly target rapidly dividing cancer cells, but often indiscriminately harm healthy cells in the process. As a result, there is a growing interest in exploring novel therapies that are both effective and less toxic to normal cells. Herbs have long been used as natural remedies for various diseases and conditions. Some herbal compounds exhibit potent anti-cancer properties, making them potential candidates for nutraceutical-based treatments. However, despite their promising efficacy, there are considerable limitations in utilizing herbal preparations due to their poor solubility, low bioavailability, rapid metabolism and excretion, as well as potential interference with other medications. Nanotechnology offers a unique platform to overcome these challenges by encapsulating herbal compounds within nanoparticles. This approach not only increases solubility and stability but also enhances the cellular uptake of nutraceuticals, allowing for controlled and targeted delivery of therapeutic agents directly at tumor sites. By harnessing the power of nanotechnology-enabled therapy, this new frontier in cancer treatment presents an opportunity to minimize toxicity while maximizing efficacy. In conclusion, this manuscript provides compelling evidence for integrating nanotechnology with nutraceuticals derived from herbal sources to optimize cancer therapy outcomes. We explore the roadblocks associated with traditional herbal treatments and demonstrate how nanotechnology can help circumvent these issues, paving the way for safer and more effective cancer interventions in future oncological practice.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23022490
003      
CZ-PrNML
005      
20240116163048.0
007      
ta
008      
240105s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fnut.2023.1258516 $2 doi
035    __
$a (PubMed)38045808
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Singla, Madhav $u Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India
245    10
$a Unlocking the power of nanomedicine: the future of nutraceuticals in oncology treatment / $c M. Singla, . Smriti, S. Gupta, P. Behal, SK. Singh, S. Preetam, S. Rustagi, J. Bora, P. Mittal, S. Malik, P. Slama
520    9_
$a Cancer, an intricate and multifaceted disease, is characterized by the uncontrolled proliferation of cells that can lead to serious health complications and ultimately death. Conventional therapeutic strategies mainly target rapidly dividing cancer cells, but often indiscriminately harm healthy cells in the process. As a result, there is a growing interest in exploring novel therapies that are both effective and less toxic to normal cells. Herbs have long been used as natural remedies for various diseases and conditions. Some herbal compounds exhibit potent anti-cancer properties, making them potential candidates for nutraceutical-based treatments. However, despite their promising efficacy, there are considerable limitations in utilizing herbal preparations due to their poor solubility, low bioavailability, rapid metabolism and excretion, as well as potential interference with other medications. Nanotechnology offers a unique platform to overcome these challenges by encapsulating herbal compounds within nanoparticles. This approach not only increases solubility and stability but also enhances the cellular uptake of nutraceuticals, allowing for controlled and targeted delivery of therapeutic agents directly at tumor sites. By harnessing the power of nanotechnology-enabled therapy, this new frontier in cancer treatment presents an opportunity to minimize toxicity while maximizing efficacy. In conclusion, this manuscript provides compelling evidence for integrating nanotechnology with nutraceuticals derived from herbal sources to optimize cancer therapy outcomes. We explore the roadblocks associated with traditional herbal treatments and demonstrate how nanotechnology can help circumvent these issues, paving the way for safer and more effective cancer interventions in future oncological practice.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Smriti, $u Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India
700    1_
$a Gupta, Saurabh $u Department of Pharmacology, Chameli Devi Institute of Pharmacy, Indore, Madhya Pradesh, India
700    1_
$a Behal, Prateek $u Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India
700    1_
$a Singh, Sachin Kumar $u School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India $u Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia
700    1_
$a Preetam, Subham $u Institute of Advanced Materials, IAAM, Ulrika, Sweden
700    1_
$a Rustagi, Sarvesh $u School of Applied and Life Sciences, Uttaranchal University, Dehradun, Uttarakhand, India
700    1_
$a Bora, Jutishna $u Amity Institute of Biotechnology, Amity University Jharkhand, Ranchi, Jharkhand, India
700    1_
$a Mittal, Pooja $u Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India
700    1_
$a Malik, Sumira $u Amity Institute of Biotechnology, Amity University Jharkhand, Ranchi, Jharkhand, India $u Department of Biotechnology, University Center for Research & Development (UCRD), Chandigarh University, Mohali, Punjab, India
700    1_
$a Slama, Petr $u Laboratory of Animal Immunology and Biotechnology, Department of Animal Morphology, Physiology and Genetics, Faculty of Agri Sciences, Mendel University in Brno, Zemedelska, Brno, Czechia
773    0_
$w MED00200569 $t Frontiers in nutrition $x 2296-861X $g Roč. 10, č. - (2023), s. 1258516
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38045808 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240105 $b ABA008
991    __
$a 20240116163045 $b ABA008
999    __
$a ok $b bmc $g 2036307 $s 1208935
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 10 $c - $d 1258516 $e 20231117 $i 2296-861X $m Frontiers in nutrition $n Front Nutr $x MED00200569
LZP    __
$a Pubmed-20240105

Find record

Citation metrics

Archiving options